三达膜(688101) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 203,109,663.47, representing a year-on-year increase of 23.62% compared to CNY 164,000,000 in the same period last year[5]. - Net profit attributable to shareholders was CNY 49,108,334.49, a decrease of 15.60% year-on-year due to a significant decline of 65.50% in investment income from joint ventures[6]. - The net profit after deducting non-recurring gains and losses was CNY 39,913,711.05, down 19.8% year-on-year[5]. - The basic and diluted earnings per share were both CNY 0.15, reflecting a decrease of 11.76% compared to the previous year[6]. - Operating profit for Q1 2023 was RMB 55,844,727.14, a decrease of 10.5% from RMB 62,425,331.75 in Q1 2022[20]. - The total profit for Q1 2023 was RMB 56,426,448.96, a decrease of 13.9% from RMB 65,515,548.82 in Q1 2022[21]. Research and Development - Research and development expenses totaled CNY 11,669,585.90, accounting for 5.75% of operating revenue, a decrease of 0.44 percentage points year-on-year[6]. - Research and development expenses increased to RMB 11,669,585.90 in Q1 2023, up from RMB 10,169,998.91 in Q1 2022, reflecting a growth of 14.7%[20]. Cash Flow and Assets - Cash flow from operating activities showed a net outflow of CNY 41,442,358.53, primarily due to a decrease in advance payments related to membrane technology projects[6]. - Cash flow from operating activities for Q1 2023 was negative at RMB -41,442,358.53, compared to a positive RMB 14,571,468.67 in Q1 2022[23]. - The company's cash and cash equivalents decreased to RMB 692,894,202.13 from RMB 1,360,139,480.12, representing a decline of approximately 49.1%[15]. - Total cash and cash equivalents at the end of Q1 2023 were RMB 690,483,840.83, down from RMB 812,910,269.91 at the end of Q1 2022[24]. - The company reported a significant increase in investment cash outflow to RMB 615,828,158.36 in Q1 2023, compared to RMB 503,825,698.25 in Q1 2022[24]. Shareholder Information - The top two shareholders, San Da Membrane Technology (Singapore) Co., Ltd. and Qingyuan (China) Co., Ltd., hold 43.36% and 25.66% of the shares, respectively[11]. Balance Sheet Highlights - The company's total assets at the end of the reporting period were CNY 5,279,643,919.07, a slight decrease of 0.36% from the end of the previous year[6]. - As of March 31, 2023, the company's total assets amounted to RMB 5,279,643,919.07, a slight decrease from RMB 5,298,919,980.32 at the end of 2022[16]. - Accounts receivable increased to RMB 702,677,625.98 from RMB 661,336,677.21, showing a growth of about 6.3%[15]. - Inventory rose to RMB 866,974,480.82 from RMB 832,415,574.87, indicating an increase of approximately 4.2%[15]. - Total current liabilities decreased to RMB 1,229,800,316.81 from RMB 1,307,636,939.38, reflecting a reduction of about 5.9%[17]. - The company's total equity increased to RMB 3,649,226,468.95 from RMB 3,598,054,979.68, marking a growth of approximately 1.4%[17]. - The long-term equity investments rose to RMB 381,944,687.60 from RMB 375,646,718.73, an increase of about 1.7%[16]. - The company's contract liabilities increased to RMB 702,861,033.06 from RMB 680,517,495.79, representing a growth of approximately 3.2%[17]. - The total non-current liabilities increased to RMB 400,617,133.31 from RMB 393,228,061.26, indicating an increase of about 1.9%[17]. - The company's retained earnings rose to RMB 1,634,107,704.61 from RMB 1,584,999,370.12, reflecting an increase of approximately 3.1%[17]. Government Subsidies - The company received government subsidies amounting to CNY 4,784,551.55, which are closely related to its normal business operations[9].